liensinine has been researched along with mk 2206 in 1 studies
| Studies (liensinine) | Trials (liensinine) | Recent Studies (post-2010) (liensinine) | Studies (mk 2206) | Trials (mk 2206) | Recent Studies (post-2010) (mk 2206) |
|---|---|---|---|---|---|
| 51 | 0 | 34 | 355 | 28 | 347 |
| Protein | Taxonomy | liensinine (IC50) | mk 2206 (IC50) |
|---|---|---|---|
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | 0.008 | |
| RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | 0.012 | |
| RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | 0.065 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, L; Jiang, Y; Liu, CM; Pan, B; Wu, Z; Zhou, J; Zhu, C | 1 |
1 other study(ies) available for liensinine and mk 2206
| Article | Year |
|---|---|
The antiandrogenic effect of neferine, liensinine, and isoliensinine by inhibiting 5-α-reductase and androgen receptor expression via PI3K/AKT signaling pathway in prostate cancer.
Topics: 5-alpha Reductase Inhibitors; Amino Acid Chloromethyl Ketones; Androgen Antagonists; Androgen Receptor Antagonists; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Benzylisoquinolines; Biological Products; Cell Line, Tumor; Cell Movement; Chromones; Heterocyclic Compounds, 3-Ring; Humans; Isoquinolines; Male; Morpholines; Nelumbo; Phenols; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction | 2021 |